Keybank National Association Neurocrine Biosciences Inc Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Keybank National Association holds 3,588 shares of NBIX stock, worth $485,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,588

Previous 3,057 17.37%

Holding current value

$485,886

Previous $420,000 1.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$114.58 - $153.15 $60,841 - $81,322	531 Added 17.37%	3,588 $413,000
Q2 2024 Jul 31, 2024	BUY	$130.86 - $143.19 $187,784 - $205,477	1,435 Added 88.47%	3,057 $420,000
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $261,843 - $288,629	-2,008 Reduced 55.32%	1,622 $223,000
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $42,321 - $52,971	-399 Reduced 9.9%	3,630 $478,000
Q3 2023 Nov 08, 2023	BUY	$94.02 - $117.1 $29,616 - $36,886	315 Added 8.48%	4,029 $453,000
Q2 2023 Aug 01, 2023	SELL	$89.53 - $104.87 $173,598 - $203,342	-1,939 Reduced 34.3%	3,714 $350,000
Q1 2023 May 10, 2023	SELL	$94.11 - $123.02 $97,497 - $127,448	-1,036 Reduced 15.49%	5,653 $572,000
Q4 2022 Jan 31, 2023	SELL	$106.72 - $127.06 $93,486 - $111,304	-876 Reduced 11.58%	6,689 $798,000
Q3 2022 Oct 27, 2022	SELL	$92.03 - $107.81 $20,154 - $23,610	-219 Reduced 2.81%	7,565 $803,000
Q2 2022 Aug 08, 2022	BUY	$75.79 - $100.07 $78,139 - $103,172	1,031 Added 15.27%	7,784 $759,000
Q1 2022 Apr 28, 2022	SELL	$72.45 - $94.81 $182,646 - $239,016	-2,521 Reduced 27.18%	6,753 $633,000
Q4 2021 Feb 07, 2022	BUY	$79.65 - $106.22 $557 - $743	7 Added 0.08%	9,274 $790,000
Q3 2021 Nov 08, 2021	BUY	$86.18 - $99.03 $98,503 - $113,191	1,143 Added 14.07%	9,267 $889,000
Q2 2021 Aug 12, 2021	SELL	$89.43 - $102.27 $48,113 - $55,021	-538 Reduced 6.21%	8,124 $791,000
Q1 2021 May 07, 2021	SELL	$87.57 - $119.4 $107,098 - $146,026	-1,223 Reduced 12.37%	8,662 $842,000
Q4 2020 Feb 09, 2021	SELL	$86.91 - $108.33 $3,650 - $4,549	-42 Reduced 0.42%	9,885 $947,000
Q3 2020 Oct 29, 2020	BUY	$96.16 - $135.15 $468,106 - $657,910	4,868 Added 96.22%	9,927 $955,000
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $430,470 - $659,491	5,059 New	5,059 $617,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Neurocrine Biosciences Inc Transaction History